(Press-News.org) MAYWOOD, Il. -- A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of options.
Loyola University Medical Center oncologist Scott E. Smith, MD, PhD presented survival data for the drug, brentuximab vedotin (Adcetris®), at the 17th Congress of the European Hematology Association. Smith is director of Loyola's Hematological Malignancies Research Program.
The multi-center study included 102 Hodgkin lymphoma patients who had relapsed after stem cell transplants. Tumors disappeared in 32 percent of patients and shrank by at least half in 40 percent of patients. An additional 21 percent of patients experienced some tumor shrinkage. Only 6 percent of patients had no response to the drug.
Sixty five percent of patients were alive at 24 months, and in 25 percent of patients, the cancer had not progressed at all.
These are "encouraging results in patients with historically poor prognosis," researchers said.
Loyola patient Michelle Salerno had failed two stem cell transplants -- one using her own cells and one using cells donated by her brother -- and multiple rounds of chemotherapy before going on brentuximab vedotin. After three or four infusions, she stopped suffering chills, sweats, high fevers and itchy pain from head to toe. And she experienced almost none of the side effects common to chemotherapy.
"I kept my hair, and never felt like vomiting," she said. "You get the drug, you go home, you feel good."
The standard regimen is a 30-minute infusion every three weeks. A patient typically receives 16 doses over 48 weeks.
Loyola has administered about 500 doses to 60 patients. "A lot of our patients are doing great on this regimen," Smith said.
Hodgkin lymphoma is a cancer of the immune system. Most patients can be cured with chemotherapy or radiation, especially when the disease is diagnosed in early stages. However, if initial treatment fails, the patient may require an autologous stem cell transplant. This procedure uses the patient's own stem cells to replace immune system cells that are destroyed by high-dose chemotherapy or radiation.
About 50 percent of patients who undergo autologus stem cell transplants relapse. Among patients who relapse, only 10 percent survive.
The Food and Drug Administration last year approved brentuximab vedotin for patients who have either failed an autologous stem cell transplant, are ineligible for a stem cell transplant or have failed two multi-drug chemotherapy regimens.
Brentuximab vedotin is an antibody attached to a powerful chemotherapy drug. The antibody acts like a homing signal, bringing the chemo drug to lymphoma cells. "Brentuximab represents a very interesting new concept in the fight against cancer," said oncologist Tulio Rodriguez, MD, who treats Salerno and is medical director of Loyola's Bone Marrow Transplantation Program. "It delivers powerful chemotherapy right where it needs to be -- into the cancer cell."
Cancer patients frequently are debilitated not only by their cancer, but also by chemotherapy treatments. Targeted drugs such as brentuximab can spare patients from the harmful effects of traditional chemotherapy, Rodriguez said.
The study found that side effects from brentuximab were generally mild. Only 9 percent of patients suffered severe peripheral neuropathy, 2 percent had extreme fatigue and 1 percent had severe diarrhea.
Salerno said the only significant side effect she experienced was mild neuropathy, which went away when the dose was lowered.
Salerno, 43, has been battling Hodgkin lymphoma for 10 years. Although she is not cured, she said, "I feel great and have a good quality of life."
Salerno, who lives in Lombard, said her treatments inspired her to start a business. She markets the Joey Pouch™ -- a small, soft pouch designed to comfortably hold the lumens of a central venous catheter so a patient can be more comfortable in daily activities or while sleeping. It is worn around the neck, next to the chest. The Joey Pouch is named after Salerno's brother, Joey, who donated stem cells used in one of her transplants.
Rodriguez said he feels immense satisfaction when he goes over CT scans with Salerno to show her how her disease is heading back into remission. But he cautioned that brentuximab, like all drugs, has potential toxicities. "Patients should talk with their doctors about the pros and cons of taking this drug and discuss whether it is best for them," Rodriguez said.
INFORMATION:
END
Menopausal women who exercise may experience fewer hot flashes in the 24 hours following physical activity, according to health researchers.
In general, women who are relatively inactive or are overweight or obese tend to have a risk of increased symptoms of perceived hot flashes, noted Steriani Elavsky, assistant professor of kinesiology at Penn State.
Perceived hot flashes do not always correspond to actual hot flashes. Most previous research analyzed only self-reported hot flashes. This is the first study known to the researchers to look at objective versus subjective ...
Women working in hedge funds struggle to be taken seriously at work, according to a new study from two leading management experts.
The report from the universities of Leicester and Essex looked into the concept of "adulting" which is defined as the attempt by people to be seen as mature and responsible, professionally and socially.
The academics, who looked at men and women at a London hedge fund, found that women faced problems at every stage of adult life – from getting started in the company to keeping credibility among colleagues after giving birth.
By contrast, ...
A new study shows significant differences in brain development in high-risk infants who develop autism starting as early as age 6 months. The findings published in the American Journal of Psychiatry reveal that this abnormal brain development may be detected before the appearance of autism symptoms in an infant's first year of life. Autism is typically diagnosed around the age of 2 or 3.
The study offers new clues for early diagnosis, which is key, as research suggests that the symptoms of autism - problems with communication, social interaction and behavior - can improve ...
CORVALLIS, Ore. – New research concludes that a one-two punch of drought and mountain pine beetle attacks are the primary forces that have killed more than 2.5 million acres of pinyon pine and juniper trees in the American Southwest during the past 15 years, setting the stage for further ecological disruption.
The widespread dieback of these tree species is a special concern, scientists say, because they are some of the last trees that can hold together a fragile ecosystem, nourish other plant and animal species, and prevent serious soil erosion.
The major form of soil ...
Gay parents face many of the same challenges as straight parents when it comes to sex and intimacy after having children, according to a new study of gay fathers published in the journal Couple and Family Psychology. The findings suggest that gay male couples who are raising children may experience lifestyle changes that could reduce their HIV risk.
"When gay couples become parents, they become very focused on the kids, they are tired, there is less time for communication and less desire for sex," said Colleen Hoff, professor of sexuality studies at San Francisco State ...
Scientists at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg have gained important insights for stem cell research which are also applicable to human tumours and could lead to the development of new treatments. As Rolf Kemler's research group discovered, a molecular link exists between the telomerase that determines the length of the telomeres and a signalling pathway known as the Wnt/β-signalling pathway.
Telomeres are the end caps of chromosomes that play a very important role in the stability of the genome. Telomeres in stem cells are long ...
Australopithecus sediba, believed to be an early relative of modern-day humans, enjoyed a diet of leaves, fruits, nuts, and bark, which meant they probably lived in a more wooded environment than is generally thought, a surprising find published in the current issue of Nature magazine by an international team of researchers that includes a Texas A&M University anthropologist.
Darryl de Ruiter, associate professor in the Department of Anthropology, says the new findings are in contrast to previously documented diets of other hominin species and suggests that Australopithecus ...
The human-occupied submersible Alvin reached a major milestone in its upgrade project on June 22 when its new titanium personnel sphere successfully completed pressure testing, reports the Woods Hole Oceanographic Institution (WHOI), the vehicle's operator.
The sphere, which holds a pilot and two scientists, is designed to descend to 6500 meters (21,000 feet or 4 miles) – depths that generate nearly 10,000 pounds per square inch (psi) of pressure on the sphere. The tests validate the sphere design and fabrication and ensure it meets the requirements of the agencies that ...
For the first time, Lawrence Livermore researchers and international collaborators have peered into the makeup of complex airborne particulate matter so small that it can be transported into human lungs -- usually without a trace.
The structure of micron-size particulate matter is important in a wide range of fields from toxicology to climate science (tobacco smoke and oil smoke particles are typically one micron in size).
However, its properties are surprisingly difficult to measure in their native environment: electron microscopy requires THE collection of particles ...
Washington, D.C.—Although there have been about 800 extra-solar planets discovered so far in our galaxy, the precise masses of the majority of them are still unknown, as the most-common planet-finding technique provides only a general idea of an object's mass. Previously, the only way to determine a planet's exact mass was if it transits—has an orbit that periodically eclipses that of its host star. Former Carnegie scientist Mercedes López-Morales has, for the first time, determined the mass of a non-transiting planet. The work is published by Astrophysical Journal Letters.
Knowing ...
